publication venue for
- Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn’s disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study 2025
- Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome 2024
- A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease 2022